Results 11 to 20 of about 19,804 (171)
Citalopram inhibits platelet function independently of SERT-mediated 5-HT transport
Scientific Reports, 2018 Citalopram prevents serotonin (5-HT) uptake into platelets by blocking the serotonin reuptake transporter (SERT). Although some clinical data suggest that selective serotonin reuptake inhibitors (SSRIs) may affect haemostasis and thrombosis, these poorly-
Harvey G. Roweth +8 more
doaj +1 more source
Postmortem Tissue Distribution of Citalopram in a Case of Carbon Monoxide Poisoning
Arab Journal of Forensic Sciences & Forensic Medicine, 2020 Citalopram abuse may impair judgment and increase the risk of suicidal thoughts. This case report aims to study the postmortem tissue distribution of citalopram in a case of carbon monoxide poisoning.
Magbool E. Oraiby +4 more
doaj +1 more source
Usefulness of serotoninergic challenge with oral citalopram [PDF]
Brazilian Journal of Psychiatry, 2006 OBJECTIVE: Challenge tests designed to evaluate serotoninergic pathways have widely used intravenous citalopram. Oral citalopram has also been used, but unsatisfactory results were obtained with a dose of 20 mg.
Paulo Mattos +4 more
doaj +1 more source
Balkan Medical Journal, 2015 Background: Citalopram is a selective serotonin reuptake inhibitor that requires routine cardiac monitoring to prevent a toxic dose. Prolongation of the QT interval has been observed in acute citalopram poisoning.
Müjgan Büyükdeligöz +4 more
doaj +1 more source
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2019 Background Recent studies have raised concerns about the reduced efficacy of citalopram when used concurrently with proton pump inhibitors. The aim of this study was to evaluate the associations between clinical use of citalopram and omeprazole and the ...
Wen‐Tung Wu +7 more
doaj +1 more source
Torsade de pointes caused by citalopram during the pacemaker battery‐depletion phase: A case report
Annals of Noninvasive Electrocardiology, 2022 Drug‐induced QT prolongation, primarily antiarrhythmic drugs, is a common cause of torsade de pointes (TdP). Although there have been previous reports of drug‐induced TdP in patients, it has not been well documented when caused by citalopram during the ...
Junwen Wang, Ziyi Sun, Siming Tao
doaj +1 more source
Impact of the antidepressant citalopram on the behaviour of two different life stages of brown trout [PDF]
PeerJ, 2020 Background Over the last two decades, there has been a constant increase in prescription rates of antidepressants. In parallel, neuroactive pharmaceuticals are making their way into aquatic environments at increasing concentrations.
Michael Ziegler +6 more
doaj +2 more sources
Citalopram – what you need to know about this proven antidepressant
Psychiatria i Psychologia Kliniczna, 2019 Citalopram is an antidepressant belonging to the group of selective serotonin reuptake inhibitors, a racemate consisting of two enantiomers: R-citalopram and S-citalopram, which show different pharmacological properties.
Piotr Wierzbiński
doaj +1 more source
Changes in QTc interval in the citalopram for agitation in Alzheimer's disease (CitAD) randomized trial. [PDF]
PLoS ONE, 2014 A Food and Drug Administration (FDA) safety communication in August 2011 warned that citalopram was associated with a dose dependent risk of QT prolongation and recommended dose restriction in patients over the age of 60 but did not provide data for this
Lea T Drye +18 more
doaj +1 more source